Nasdaq-Listed US Company Enters This Altcoin with Loads! “Becoming the First Company!”

Last July, Nasdaq-listed MEI Pharma announced its move for a crypto reserve and chose Litecoin (LTC) for it.

Following this announcement, MEI Pharma implemented its reserve strategy and purchased $100 million worth of LTC.

According to the official announcement, MEI Pharma made its first LTC purchase and launched a $100 million corporate treasury strategy with Litecoin founder Charlie Lee and GSR acting as advisors.

MEI Pharma announced today that it has purchased 929,548 Litecoin at an average price of $107.58, successfully launching a major corporate treasury strategy that will see its LTC treasury valued at approximately $110.4 million as of August 4, 2025.

MEI Pharma has become the first US-listed public company to adopt Litecoin as its primary reserve asset.

“Litecoin has long been the symbol of a robust, scalable, and decentralized currency. By launching this strategy, MEI is taking a clear, institutional step that recognizes Litecoin’s role as both a reserve asset and an integral part of global financial systems,” said Charlie Lee.

Litecoin has seen a massive surge compared to other altcoins in the last 24 hours, rising 7% to $123.8.

*This is not investment advice.

Source